secwatch.observer — SEC 8-K summary
======================================

Issuer:     ICU MEDICAL INC/DE (ICUI)
CIK:        0000883984
Form:       8-K
Filed at:   2026-08-06T20:11:02+00:00
Accession:  0000883984-26-000040
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ICU Medical Q2 GAAP EPS $0.76, adjusted EPS $2.37; organic revenue up 6%
------------------------------------------------------------------------

- GAAP revenue $551.7M (+1% YoY); non-GAAP organic revenue +6% excluding IV Solutions divestiture and FX.
- GAAP net income $19.1M ($0.76 diluted EPS) vs $35.3M ($1.43) in Q2 2025.
- Adjusted diluted EPS $2.37 vs $2.10; adjusted EBITDA $110.0M vs $100.3M.
- GAAP gross margin improved to 43% from 38% YoY.
- FY2026 guidance updated; specific numbers not available in provided excerpt.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/883984/000088398426000040/0000883984-26-000040-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/883984/000088398426000040/icui-20260806.htm
  HTML page:      https://secwatch.observer/filing/0000883984-26-000040

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer